NECTAR LIFESCIENCES
Back to Cashflow Statement
|
NECTAR LIFESCIENCES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-767 Cr | ₹-128 Cr | ₹-205 Cr | ₹-186 Cr | ₹-119 Cr |
What is the latest Cash Flow from Financing Activities ratio of NECTAR LIFESCIENCES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-767 Cr |
| Mar2025 | ₹-128 Cr |
| Mar2024 | ₹-205 Cr |
| Mar2023 | ₹-186 Cr |
| Mar2022 | ₹-119 Cr |
How is Cash Flow from Financing Activities of NECTAR LIFESCIENCES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-767 Cr | Negative | |
| Mar2025 | ₹-128 Cr | Negative | |
| Mar2024 | ₹-205 Cr | Negative | |
| Mar2023 | ₹-186 Cr | Negative | |
| Mar2022 | ₹-119 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹209.5 Cr | 12.4% | 3% | -18.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,831.0 Cr | -0.2% | -4.9% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹242,074.0 Cr | 1.3% | -2.3% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,355.0 Cr | -1.5% | -5.8% | 29.3% | Stock Analytics | |
| CIPLA | ₹107,439.0 Cr | 0.1% | -4.2% | -14.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,417.0 Cr | 1.9% | 5.7% | 0.4% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | 12.4% |
3% |
-18.5% |
| SENSEX | 0.6% |
-1.4% |
-10.7% |
You may also like the below Video Courses